LEMAITRE VASCULAR INC (LMAT) Stock Fundamental Analysis
NASDAQ:LMAT - Nasdaq - US5255582018 - Common Stock - Currency: USD
LMAT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making LMAT a very profitable company, without any liquidiy or solvency issues. LMAT has a decent growth rate and is not valued too expensively. With these ratings, LMAT could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year LMAT was profitable.
LMAT had a positive operating cash flow in the past year.
In the past 5 years LMAT has always been profitable.
In the past 5 years LMAT always reported a positive cash flow from operatings.
1.2 Ratios
LMAT has a Return On Assets of 8.12%. This is amongst the best in the industry. LMAT outperforms 91.44% of its industry peers.
LMAT has a Return On Equity of 12.99%. This is amongst the best in the industry. LMAT outperforms 89.84% of its industry peers.
LMAT has a Return On Invested Capital of 7.67%. This is amongst the best in the industry. LMAT outperforms 86.10% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LMAT is in line with the industry average of 7.89%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.12% | ||
| ROE | 12.99% | ||
| ROIC | 7.67% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
LMAT's Profit Margin of 19.96% is amongst the best of the industry. LMAT outperforms 94.65% of its industry peers.
LMAT's Profit Margin has improved in the last couple of years.
LMAT has a Operating Margin of 23.43%. This is amongst the best in the industry. LMAT outperforms 94.12% of its industry peers.
LMAT's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 68.80%, LMAT is doing good in the industry, outperforming 77.54% of the companies in the same industry.
LMAT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.43% | ||
| PM (TTM) | 19.96% | ||
| GM | 68.8% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LMAT is destroying value.
Compared to 1 year ago, LMAT has more shares outstanding
LMAT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, LMAT has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 7.29 indicates that LMAT is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 7.29, LMAT belongs to the best of the industry, outperforming 85.56% of the companies in the same industry.
LMAT has a debt to FCF ratio of 4.09. This is a neutral value as LMAT would need 4.09 years to pay back of all of its debts.
LMAT has a Debt to FCF ratio of 4.09. This is amongst the best in the industry. LMAT outperforms 85.56% of its industry peers.
A Debt/Equity ratio of 0.48 indicates that LMAT is not too dependend on debt financing.
LMAT's Debt to Equity ratio of 0.48 is in line compared to the rest of the industry. LMAT outperforms 42.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 4.09 | ||
| Altman-Z | 7.29 |
ROIC/WACC0.87
WACC8.82%
2.3 Liquidity
A Current Ratio of 16.49 indicates that LMAT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 16.49, LMAT belongs to the top of the industry, outperforming 97.86% of the companies in the same industry.
LMAT has a Quick Ratio of 13.83. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
LMAT has a better Quick ratio (13.83) than 95.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 16.49 | ||
| Quick Ratio | 13.83 |
3. Growth
3.1 Past
LMAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.13%, which is quite impressive.
LMAT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.13% yearly.
LMAT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.19%.
The Revenue has been growing by 13.41% on average over the past years. This is quite good.
EPS 1Y (TTM)31.13%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%9.09%
Revenue 1Y (TTM)13.19%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.95%
3.2 Future
Based on estimates for the next years, LMAT will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.65% on average per year.
The Revenue is expected to grow by 9.07% on average over the next years. This is quite good.
EPS Next Y13.23%
EPS Next 2Y11.97%
EPS Next 3Y12.28%
EPS Next 5Y8.65%
Revenue Next Year11.52%
Revenue Next 2Y10.16%
Revenue Next 3Y10.14%
Revenue Next 5Y9.07%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 41.80, the valuation of LMAT can be described as expensive.
LMAT's Price/Earnings ratio is a bit cheaper when compared to the industry. LMAT is cheaper than 70.59% of the companies in the same industry.
When comparing the Price/Earnings ratio of LMAT to the average of the S&P500 Index (28.05), we can say LMAT is valued slightly more expensively.
With a Price/Forward Earnings ratio of 34.02, LMAT can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, LMAT is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.67, LMAT is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.8 | ||
| Fwd PE | 34.02 |
4.2 Price Multiples
LMAT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LMAT is cheaper than 72.73% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, LMAT is valued a bit cheaper than 76.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 45.47 | ||
| EV/EBITDA | 23.08 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of LMAT may justify a higher PE ratio.
LMAT's earnings are expected to grow with 12.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.16
PEG (5Y)2.44
EPS Next 2Y11.97%
EPS Next 3Y12.28%
5. Dividend
5.1 Amount
With a yearly dividend of 0.99%, LMAT is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.78, LMAT pays a better dividend. On top of this LMAT pays more dividend than 92.51% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, LMAT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.99% |
5.2 History
The dividend of LMAT is nicely growing with an annual growth rate of 13.60%!
LMAT has been paying a dividend for at least 10 years, so it has a reliable track record.
LMAT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
LMAT pays out 33.89% of its income as dividend. This is a sustainable payout ratio.
LMAT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP33.89%
EPS Next 2Y11.97%
EPS Next 3Y12.28%
NASDAQ:LMAT (7/28/2025, 2:11:26 PM)
82.755
+0.32 (+0.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners94.92%
Inst Owner Change0.84%
Ins Owners8.54%
Ins Owner Change-3.07%
Market Cap1.87B
Analysts76.47
Price Target106.59 (28.8%)
Short Float %7.05%
Short Ratio8.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.99% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP33.89%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.01%
Min EPS beat(2)-5.52%
Max EPS beat(2)-2.5%
EPS beat(4)2
Avg EPS beat(4)2.64%
Min EPS beat(4)-5.52%
Max EPS beat(4)10.44%
EPS beat(8)6
Avg EPS beat(8)5.59%
EPS beat(12)7
Avg EPS beat(12)-0.64%
EPS beat(16)8
Avg EPS beat(16)-1.01%
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)1.83%
Revenue beat(4)2
Avg Revenue beat(4)-0.13%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)7
Avg Revenue beat(16)-0.34%
PT rev (1m)0%
PT rev (3m)-1.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.06%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.64%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.6%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.8 | ||
| Fwd PE | 34.02 | ||
| P/S | 8.26 | ||
| P/FCF | 45.47 | ||
| P/OCF | 38.87 | ||
| P/B | 5.38 | ||
| P/tB | 7.56 | ||
| EV/EBITDA | 23.08 |
EPS(TTM)1.98
EY2.39%
EPS(NY)2.43
Fwd EY2.94%
FCF(TTM)1.82
FCFY2.2%
OCF(TTM)2.13
OCFY2.57%
SpS10.02
BVpS15.39
TBVpS10.94
PEG (NY)3.16
PEG (5Y)2.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.12% | ||
| ROE | 12.99% | ||
| ROCE | 9.98% | ||
| ROIC | 7.67% | ||
| ROICexc | 17.81% | ||
| ROICexgc | 31.73% | ||
| OM | 23.43% | ||
| PM (TTM) | 19.96% | ||
| GM | 68.8% | ||
| FCFM | 18.17% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexcg growth 3Y-0.4%
ROICexcg growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 4.09 | ||
| Debt/EBITDA | 2.67 | ||
| Cap/Depr | 70.88% | ||
| Cap/Sales | 3.08% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 76.52% | ||
| Profit Quality | 91.04% | ||
| Current Ratio | 16.49 | ||
| Quick Ratio | 13.83 | ||
| Altman-Z | 7.29 |
F-Score5
WACC8.82%
ROIC/WACC0.87
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)31.13%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%9.09%
EPS Next Y13.23%
EPS Next 2Y11.97%
EPS Next 3Y12.28%
EPS Next 5Y8.65%
Revenue 1Y (TTM)13.19%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.95%
Revenue Next Year11.52%
Revenue Next 2Y10.16%
Revenue Next 3Y10.14%
Revenue Next 5Y9.07%
EBIT growth 1Y29.64%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year37.67%
EBIT Next 3Y21.1%
EBIT Next 5YN/A
FCF growth 1Y126.79%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y109.55%
OCF growth 3Y7.93%
OCF growth 5Y25.49%